Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving lenalidomide together with prednisone works
in treating patients with myelofibrosis. Lenalidomide may stop the growth of myelofibrosis by
blocking blood flow to the cancer. It may also stimulate the immune system in different ways
and stop cancer cells from growing. Drugs used in chemotherapy, such as prednisone, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Giving lenalidomide together with prednisone may kill more cancer cells.